A US federal jury awards Apple $250, finding that Masimo's smartwatches infringed Apple Watch design patents; Apple sought statutory minimum damages
but it won't affect Apple Watch's MIA blood oxygen feature John Quintet / iPhone in Canada Blog : Apple Wins $250 in Smartwatch Patent Case Against Masimo Akash Pandey / NewsBytes : Apple wins a patent infringement lawsuit against Masimo, awarded $250 Devesh Beri / The Mac Observer : Apple Wins Patent Lawsuit Against Masimo, but Blood Oxygen Functionality Won't Return Jay Peters / The Verge : Apple wins a battle (and $250) in its smartwatch patent fight with Masimo Threads: @eshumarneedi : At this point, they should get Tim Cook and John Masimo or whoever the hell the new Masimo CEO is and put them in a cage fight. https://www.theverge.com/... X: Florian Mueller / @florian4gamers : Here's the thing to understand about Apple's symbolic but strategic win over Masimo: Masimo never had a serious opportunity in smartwatches and only made them to satisfy the domestic industry requirement of the USITC so they could win an import ban against Apple. Josh Long / @thejoshmeister : @9to5mac @ChanceHMiller Good. 🔜 Maybe this ruling will help facilitate finally enabling the O₂ sensor in U.S.-sold Apple Watch units from the past year. https://x.com/... Dylan / @dylanmcd8 : 💀💀💀💀💀💀💀💀💀 Forums: Hacker News : Apple wins $250 US jury verdict in patent case over Masimo smartwatches r/gadgets : Apple wins 250 Dollars in Masimo smartwatch patent case / The company says its ultimate goal wasn't money, but to get an injunction. r/AppleWatch : Jury rules Masimo smartwatches infringe Apple design patents
Context & Ripple Effects
This is one front in a reciprocal Apple–Masimo IP dispute that began when Apple alleged Masimo had studied and copied its intellectual property in the 2022 lawsuit over Masimo's W1 watch.
The design-patent verdict is separate from the health-sensing fight: an ITC judge had previously found that some Apple Watches infringed a Masimo pulse-oximeter patent, putting blood-oxygen measurement at the center of the broader dispute.
First-order effects
- Apple receives the statutory-minimum $250 award, while Masimo has a jury finding against its smartwatch designs.
- The ruling does not change the absence of the blood-oxygen feature on U.S. Apple Watch units, leaving the product consequence of the separate sensing-patent dispute intact.
Second-order effects
- The outcome clarifies that the parties' claims operate on different layers—watch design versus blood-oxygen sensing—so a win on one track does not settle the other.
- Masimo and Apple must continue to treat smartwatch design choices and health-feature implementation as distinct litigation and product-risk areas.
Third-order effects
- If this pattern persists, wearable competition will be shaped not only by device features but by overlapping rights in industrial design and sensor technology, with remedies affecting different parts of a product independently.
- The dispute illustrates how patent conflicts can fragment product availability: a favorable verdict for one party may have little bearing on whether a contested health feature can return.
The trend: Wearable IP battles are becoming increasingly modular, separating claims over device design from claims over the sensing technologies that enable health features.